Publications Menu
California’s current homelessness crisis is unprecedented. In early 2020, more than 160,000 persons experienced homelessness on any given day, representing a 40% increase since 2015. Effects on individuals experiencing housing insecurity and the community's public health have been profound, including recent outbreaks of hepatitis A and typhus in communities experiencing homelessness.
California’s current homelessness crisis is unprecedented. In early 2020, more than 160,000 persons experienced homelessness on any given day, representing a 40% increase since 2015. Effects on individuals experiencing housing insecurity and the community's public health have been profound, including recent outbreaks of hepatitis A and typhus in communities experiencing homelessness.
UCLA Faculty Associate Mark Peterson has a chapter "The Third Rail of Politics? Medicare's Untouchability" in this book assessing Medicare and Medicaid at 50, edited by Alan B. Cohen, et al. For 50 years, Medicare and Medicaid have stood at the center of a contentious debate surrounding American government, citizenship, and health care entitlement.
UCLA Faculty Associate Mark Peterson has a chapter "The Third Rail of Politics? Medicare's Untouchability" in this book assessing Medicare and Medicaid at 50, edited by Alan B. Cohen, et al. For 50 years, Medicare and Medicaid have stood at the center of a contentious debate surrounding American government, citizenship, and health care entitlement.
BACKGROUND: Despite the lack of evidence demonstrating a survival benefit from prostate-specific antigen (PSA) screening, its use has become widespread, organizations have encouraged physicians to discuss early detection of prostate carcinoma, and two higher risk groups have been recognized.
BACKGROUND: Despite the lack of evidence demonstrating a survival benefit from prostate-specific antigen (PSA) screening, its use has become widespread, organizations have encouraged physicians to discuss early detection of prostate carcinoma, and two higher risk groups have been recognized.
BACKGROUND: Despite the lack of evidence demonstrating a survival benefit from prostate-specific antigen (PSA) screening, its use has become widespread, organizations have encouraged physicians to discuss early detection of prostate carcinoma, and two higher risk groups have been recognized.
BACKGROUND: Despite the lack of evidence demonstrating a survival benefit from prostate-specific antigen (PSA) screening, its use has become widespread, organizations have encouraged physicians to discuss early detection of prostate carcinoma, and two higher risk groups have been recognized.